发明名称 COMPOSTO REPRESENTADO PELA FORMULA GERAL (1) OU UM SAL FARMECEUTICAMENTE ACEITÁVEL DO MESMO; MÉTODO PARA O TRATAMENTO OU PREVENÇÃO DE DIABETES ; USO DO COMPOSTO; COMPOSIÇÃO FARMACÊUTICA E COMPOSTO REPRESENTADO PELA FORMULA GERAL (3).
摘要 A compound, or a pharmaceutically acceptable salt thereof, represented by the formula (1), (wherein, the carbon atom marked with an * is in the R-configuration, R 1 represents a hydrogen atom, a halogen atom, an amino group, a hydroxyl group, a hydroxyamino group, a nitro group, a cyano group, a sulfamoyl group, a C 1 -C 6 alkyl group, or a C 1 -C 6 alkoxy group, R 2 represents a C 3 -C 6 cycloalkylsulfanyl group, a C 3 -C 6 cycloalkylsulfinyl group, or a C 3 -C 6 cycloalkylsulfonyl group, and A represents a substituted or unsubstituted heteroaryl group).
申请公布号 BRPI0808267(A2) 申请公布日期 2014.07.22
申请号 BR2008PI08267 申请日期 2008.03.06
申请人 KYORIN PHAMACEUTICAL CO., LTD;TEIJIN PHARMA LIMITED 发明人 YASUMICHI FUKUDA;YOSHIKAZU ASAHINA;MASANORI TAKADOI;KOHEI OHATA;TOMOHIRO IDE;FUMIYOSHI KOBAYASHI;SHINJI KOBAYASHI;SHINJI KOBAYASHI;KANJI KOMATSU;MASANORI YAMAMOTO
分类号 C07D213/75;A61K31/415;A61K31/421;A61K31/426;A61K31/433;A61K31/437;A61K31/4965;A61P3/04;A61P3/10;A61P43/00;C07D231/38;C07D241/20;C07D263/14;C07D277/20;C07D277/46;C07D277/56;C07D285/12;C07D405/04;C07D405/12;C07D417/04;C07D498/04;C07D513/04 主分类号 C07D213/75
代理机构 代理人
主权项
地址